Mus caroli (Ryukyu mouse): 110290454
Help
Entry
110290454 CDS
T05910
Gene name
Plcg1
Definition
(RefSeq) 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1
KO
K01116
phosphatidylinositol phospholipase C, gamma-1 [EC:
3.1.4.11
]
Organism
mcal
Mus caroli (Ryukyu mouse)
Pathway
mcal00562
Inositol phosphate metabolism
mcal01100
Metabolic pathways
mcal01521
EGFR tyrosine kinase inhibitor resistance
mcal04012
ErbB signaling pathway
mcal04014
Ras signaling pathway
mcal04015
Rap1 signaling pathway
mcal04020
Calcium signaling pathway
mcal04062
Chemokine signaling pathway
mcal04064
NF-kappa B signaling pathway
mcal04066
HIF-1 signaling pathway
mcal04070
Phosphatidylinositol signaling system
mcal04072
Phospholipase D signaling pathway
mcal04360
Axon guidance
mcal04370
VEGF signaling pathway
mcal04613
Neutrophil extracellular trap formation
mcal04650
Natural killer cell mediated cytotoxicity
mcal04658
Th1 and Th2 cell differentiation
mcal04659
Th17 cell differentiation
mcal04660
T cell receptor signaling pathway
mcal04664
Fc epsilon RI signaling pathway
mcal04666
Fc gamma R-mediated phagocytosis
mcal04670
Leukocyte transendothelial migration
mcal04722
Neurotrophin signaling pathway
mcal04750
Inflammatory mediator regulation of TRP channels
mcal04919
Thyroid hormone signaling pathway
mcal04933
AGE-RAGE signaling pathway in diabetic complications
mcal04935
Growth hormone synthesis, secretion and action
mcal05012
Parkinson disease
mcal05022
Pathways of neurodegeneration - multiple diseases
mcal05135
Yersinia infection
mcal05167
Kaposi sarcoma-associated herpesvirus infection
mcal05170
Human immunodeficiency virus 1 infection
mcal05171
Coronavirus disease - COVID-19
mcal05200
Pathways in cancer
mcal05205
Proteoglycans in cancer
mcal05206
MicroRNAs in cancer
mcal05214
Glioma
mcal05223
Non-small cell lung cancer
mcal05225
Hepatocellular carcinoma
mcal05231
Choline metabolism in cancer
mcal05235
PD-L1 expression and PD-1 checkpoint pathway in cancer
Module
mcal_M00130
Inositol phosphate metabolism, PI=> PIP2 => Ins(1,4,5)P3 => Ins(1,3,4,5)P4
Brite
KEGG Orthology (KO) [BR:
mcal00001
]
09100 Metabolism
09101 Carbohydrate metabolism
00562 Inositol phosphate metabolism
110290454 (Plcg1)
09130 Environmental Information Processing
09132 Signal transduction
04012 ErbB signaling pathway
110290454 (Plcg1)
04014 Ras signaling pathway
110290454 (Plcg1)
04015 Rap1 signaling pathway
110290454 (Plcg1)
04370 VEGF signaling pathway
110290454 (Plcg1)
04064 NF-kappa B signaling pathway
110290454 (Plcg1)
04066 HIF-1 signaling pathway
110290454 (Plcg1)
04020 Calcium signaling pathway
110290454 (Plcg1)
04070 Phosphatidylinositol signaling system
110290454 (Plcg1)
04072 Phospholipase D signaling pathway
110290454 (Plcg1)
09150 Organismal Systems
09151 Immune system
04613 Neutrophil extracellular trap formation
110290454 (Plcg1)
04650 Natural killer cell mediated cytotoxicity
110290454 (Plcg1)
04660 T cell receptor signaling pathway
110290454 (Plcg1)
04658 Th1 and Th2 cell differentiation
110290454 (Plcg1)
04659 Th17 cell differentiation
110290454 (Plcg1)
04664 Fc epsilon RI signaling pathway
110290454 (Plcg1)
04666 Fc gamma R-mediated phagocytosis
110290454 (Plcg1)
04670 Leukocyte transendothelial migration
110290454 (Plcg1)
04062 Chemokine signaling pathway
110290454 (Plcg1)
09152 Endocrine system
04935 Growth hormone synthesis, secretion and action
110290454 (Plcg1)
04919 Thyroid hormone signaling pathway
110290454 (Plcg1)
09156 Nervous system
04722 Neurotrophin signaling pathway
110290454 (Plcg1)
09157 Sensory system
04750 Inflammatory mediator regulation of TRP channels
110290454 (Plcg1)
09158 Development and regeneration
04360 Axon guidance
110290454 (Plcg1)
09160 Human Diseases
09161 Cancer: overview
05200 Pathways in cancer
110290454 (Plcg1)
05206 MicroRNAs in cancer
110290454 (Plcg1)
05205 Proteoglycans in cancer
110290454 (Plcg1)
05231 Choline metabolism in cancer
110290454 (Plcg1)
05235 PD-L1 expression and PD-1 checkpoint pathway in cancer
110290454 (Plcg1)
09162 Cancer: specific types
05225 Hepatocellular carcinoma
110290454 (Plcg1)
05214 Glioma
110290454 (Plcg1)
05223 Non-small cell lung cancer
110290454 (Plcg1)
09164 Neurodegenerative disease
05012 Parkinson disease
110290454 (Plcg1)
05022 Pathways of neurodegeneration - multiple diseases
110290454 (Plcg1)
09167 Endocrine and metabolic disease
04933 AGE-RAGE signaling pathway in diabetic complications
110290454 (Plcg1)
09171 Infectious disease: bacterial
05135 Yersinia infection
110290454 (Plcg1)
09172 Infectious disease: viral
05170 Human immunodeficiency virus 1 infection
110290454 (Plcg1)
05171 Coronavirus disease - COVID-19
110290454 (Plcg1)
05167 Kaposi sarcoma-associated herpesvirus infection
110290454 (Plcg1)
09176 Drug resistance: antineoplastic
01521 EGFR tyrosine kinase inhibitor resistance
110290454 (Plcg1)
09180 Brite Hierarchies
09182 Protein families: genetic information processing
04131 Membrane trafficking [BR:
mcal04131
]
110290454 (Plcg1)
Enzymes [BR:
mcal01000
]
3. Hydrolases
3.1 Acting on ester bonds
3.1.4 Phosphoric-diester hydrolases
3.1.4.11 phosphoinositide phospholipase C
110290454 (Plcg1)
Membrane trafficking [BR:
mcal04131
]
Exocytosis
Calcium ion-dependent exocytosis
Phospholipases
110290454 (Plcg1)
Endocytosis
Macropinocytosis
Phospholipase C
110290454 (Plcg1)
BRITE hierarchy
SSDB
Ortholog
Paralog
GFIT
Motif
Pfam:
PI-PLC-X
SH2
PI-PLC-Y
SH3_1
C2
PH
SH3_9
SH3_2
PH_12
GDPD
PH_9
Motif
Other DBs
NCBI-GeneID:
110290454
NCBI-ProteinID:
XP_021012651
Ensembl:
MGP_CAROLIEiJ_G0024600
UniProt:
A0A6P5PEA9
LinkDB
All DBs
Position
2
AA seq
1290 aa
AA seq
DB search
MAGVATPCANGCGPGAPSEAEVLHLCRSLEVGTVMTLFYSKKSQRPERKTFQVKLETRQI
TWSRGADKIEGSIDIREIKEIRPGKTSRDFDRYQEDPAFRPDQSHCFVILYGMEFRLKTL
SLQATSEDEVNMWIKGLTWLMEDTLQAATPLQIERWLRKQFYSVDRNREDRISAKDLKNM
LSQVNYRVPNMRFLRERLTDLEQRSGDITYGQFAQLYRSLMYSAQKTMDLPFLETSALRT
GERPEHCQVSLSEFQQFLLEYQGELWAVDRLRVQEFMLSFLRDPLREVEEPYLFLDELVT
FLFSKENSVWNSQLDAVCPDTMNNPLSHYWISSSHNTYLTGDQFSSESSLEAYARCLRMG
CRCIELDCWDGPDGMPVIYHGHTLTTKIKFSDVLHTIKEHAFVASEYPVILSIEDHCSIA
QQRNMAQHFRKVLGDTLLTKPVDIAADGLPSPNQLKRKILIKHKKLAEGSAYEEVPTSVM
YSENDISNSIKNGILYLEDPVNHEWYPHYFVLTSSKIYYSEETNSDQGNEDEEEPKEASS
STELHSSEKWFHGKLGAGRDGRHIAERLLTEYCIETGAPDGSFLVRESETFVGDYTLSFW
RNGKVQHCRIHSRQDAGTPKFFLTDNLVFDSLYDLITHYQQVPLRCNEFEMRLSEPVPQT
NAHESKEWYHASLTRAQAEHMLMRVPRDGAFLVRKRNEPNSYAISFRAEGKIKHCRVQQE
GQTVMLGNSEFDSLVDLISYYEKHPLYRKMKLRYPINEEALEKIGTAEPDYGALYEGRNP
GFYVEANPMPTFKCAVKALFDYKAQREDELTFTKSAIIQNVEKQDGGWWRGDYGGKKQLW
FPSNYVEEMINPAVLEPEREHLDENSPLGDLLRGVLDVPACQIAIRPEGKNNRLFVFSIS
MPSVAQWSLDVAADSQEELQDWVKKIREVAQTADARLTEGKMMERRKKIALELSELVVYC
RPVPFDEEKIGTERACYRDMSSFPETKAEKYVNKAKGKKFLQYNRLQLSRIYPKGQRLDS
SNYDPLPMWICGSQLVALNFQTPDKPMQMNQALFMAGGHCGYVLQPSTMRDEAFDPFDKS
SLRGLEPCVICIEVLGARHLPKNGRGIVCPFVEIEVAGAEYDSTKQKTEFVVDNGLNPVW
PAKPFHFQISNPEFAFLRFVVYEEDMFSDQNFLAQATFPVKGLKTGYRAVPLKNNYSEDL
ELASLLIKIDIFPAKENGDLSPFSGISLRERASDASSQLFHVRGREGSFEARYQQPFEDF
RISQEHLADHFDSRERRAPRRTRVNGDNRL
NT seq
3873 nt
NT seq
+upstream
nt +downstream
nt
atggctggcgtcgcgaccccctgcgccaacggctgcgggcccggcgcgccctccgaagcc
gaggtgctgcacctctgccgcagcctcgaggtgggcaccgtcatgactttgttctactcc
aagaagtcgcagcggccagaacggaagaccttccaggtcaagttggagacgcgccagatc
acatggagccgcggcgcggacaaaatcgaggggtccattgatatccgagaaatcaaggag
atccgtccagggaagacgtcacgggactttgaccgctaccaagaagaccctgccttccgg
ccagatcaatcacactgctttgtcatcctctatggaatggaattccgcttgaagaccctg
agcctgcaagccacatctgaggatgaagtgaacatgtggatcaagggcttaacttggctg
atggaggatacactgcaggcagccacacccctgcaaattgagaggtggctccggaagcag
ttctactcagtggatcggaaccgagaggatcgtatatcagccaaggacttgaagaacatg
ctgtctcaggtcaactaccgagtccccaatatgcgcttcctccgagagcggctgacggac
cttgaacagcgcagcggggacatcacctacgggcagtttgctcagctgtaccgcagcctc
atgtacagcgcccagaagacgatggaccttcccttcttggaaaccagcgctttgaggact
ggagagcggccggagcattgccaggtgtccctttctgagttccagcagttccttcttgaa
taccagggggagctgtgggctgtggaccggctccgggtgcaggaattcatgctcagcttc
cttcgagaccccttgcgagaggttgaggagccgtacttgttcttggatgagcttgtcacc
ttcctgttctccaaagagaatagtgtgtggaactcacagctggatgctgtgtgcccagac
accatgaacaacccactctctcactattggatctcctcctcacataatacgtacctgact
ggggaccagttctccagtgagtcctccctggaagcctatgctcgctgcctgaggatgggc
tgtcgctgcattgagttggactgctgggatgggccagatgggatgccagtcatttaccat
gggcacactctcaccaccaagatcaagttctctgacgtcctgcacaccatcaaggagcat
gctttcgtagcctccgagtacccagtcatcctgtccatcgaggaccactgcagcattgcc
cagcagagaaacatggctcagcacttcagaaaggtgcttggcgacacactccttaccaag
cctgtggacattgctgctgatgggcttccttctcccaaccagctcaagaggaagatcctt
attaagcacaagaagctggctgagggcagtgcctatgaggaggtgcctacctctgtgatg
tactccgagaatgacatcagtaactccatcaagaatggtatcctctacttggaggacccc
gtgaatcatgagtggtatccccactacttcgttctgacgagcagcaagatctactactct
gaggagaccaacagtgaccagggcaatgaggatgaagaggagccgaaggaggccagcagc
agcacagagctgcactcgagtgagaagtggttccacgggaagctcggggctggacgtgat
gggcggcacattgctgagcgcctgctcactgagtactgcatagagactggggctcctgat
ggctccttcctagtgcgagaaagtgagaccttcgtgggtgactacacgctgtccttctgg
cggaatgggaaagtccagcactgccgcatccattcccggcaggatgctgggactcctaag
ttcttcttgacagataaccttgtctttgactctctctatgacctcatcacacattatcag
caagtacccctgcgctgcaatgagtttgagatgcgcctttcagagcctgttccacagacg
aatgcccatgaaagcaaagagtggtaccatgcaagcctgactagagctcaggctgaacat
atgctgatgcgagtgccccgggatggggccttcctggtgcggaaacgcaatgagcctaac
tcatacgccatctctttccgggctgagggaaagatcaagcactgccgagtacagcaggaa
ggccagactgtgatgctggggaactctgagtttgacagcctggttgacctcatcagctac
tatgagaagcaccccctgtaccgcaaaatgaagctacgctaccccatcaacgaggaggca
ctggagaagattgggacagctgaacccgattatggggcactatatgagggccgcaaccct
ggtttctatgtggaggcaaaccctatgccaactttcaagtgtgcagtaaaagccctcttc
gactacaaggcccagagagaggatgagctgaccttcaccaagagtgccatcatccagaat
gtggaaaagcaagatggtggctggtggcgaggggactatggtgggaagaagcagctgtgg
ttcccctcaaactatgtggaagagatgatcaatccagcagtcctagagcctgagagggag
cacctggatgaaaacagcccactgggggacttgctgcgaggggtcttagatgtgccagct
tgtcagatcgcaatccgtcctgagggcaaaaacaaccggctcttcgtcttctccatcagc
atgccgtcagtggctcagtggtccctggatgttgcagctgactcacaggaggagttacag
gactgggtgaaaaagatccgtgaagttgcccagactgcagatgccaggctcactgagggg
aagatgatggagaggaggaagaagatcgccttggagctttccgagcttgtggtctactgc
cggcccgttccctttgatgaagagaagattggcacagaacgtgcttgttaccgggacatg
tcctcctttccggaaaccaaggctgagaagtatgtgaacaaggccaaaggcaagaagttc
ctccagtacaaccggctgcagctctctcgcatctaccccaagggccagaggctggactcc
tccaattatgatcctctgcccatgtggatctgcggcagccagcttgtagcactcaatttc
cagaccccagacaagcctatgcagatgaaccaggccctcttcatggctggtgggcattgt
ggctatgtgctgcagccaagcaccatgagagacgaagcctttgacccctttgataagagc
agtctccgaggtctggaaccctgtgtcatttgcattgaggtgctgggggccaggcatctg
ccgaagaatggccggggtattgtgtgtccttttgtggagattgaggtggctggggctgag
tacgacagcaccaagcaaaagacggagtttgtagtggacaacggactgaaccctgtgtgg
cccgctaagcccttccacttccagatcagtaacccagagtttgcctttctgcgctttgtg
gtgtatgaggaagacatgtttagtgaccagaacttcttggctcaggctactttcccagta
aaaggcctgaagacaggatatagagcagtgcctttgaagaacaactacagtgaagacctg
gagttggcctccctgctcatcaagattgacattttccctgctaaggagaacggtgacctc
agtcctttcagtggcatatccctaagggaacgggcctcagatgcctccagccagctgttc
catgtccggggccgggaagggtcctttgaagccagataccagcagccatttgaagatttc
cgcatctcgcaggagcatcttgcagaccattttgacagtcgggaacgaagggccccaaga
aggactcgggtcaatggagacaaccgcctctag
Mus caroli (Ryukyu mouse): 110300336
Help
Entry
110300336 CDS
T05910
Gene name
Plcg2
Definition
(RefSeq) 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2 isoform X1
KO
K05859
phosphatidylinositol phospholipase C, gamma-2 [EC:
3.1.4.11
]
Organism
mcal
Mus caroli (Ryukyu mouse)
Pathway
mcal00562
Inositol phosphate metabolism
mcal01100
Metabolic pathways
mcal01521
EGFR tyrosine kinase inhibitor resistance
mcal04012
ErbB signaling pathway
mcal04014
Ras signaling pathway
mcal04020
Calcium signaling pathway
mcal04062
Chemokine signaling pathway
mcal04064
NF-kappa B signaling pathway
mcal04066
HIF-1 signaling pathway
mcal04070
Phosphatidylinositol signaling system
mcal04072
Phospholipase D signaling pathway
mcal04360
Axon guidance
mcal04370
VEGF signaling pathway
mcal04380
Osteoclast differentiation
mcal04611
Platelet activation
mcal04613
Neutrophil extracellular trap formation
mcal04625
C-type lectin receptor signaling pathway
mcal04650
Natural killer cell mediated cytotoxicity
mcal04662
B cell receptor signaling pathway
mcal04664
Fc epsilon RI signaling pathway
mcal04666
Fc gamma R-mediated phagocytosis
mcal04670
Leukocyte transendothelial migration
mcal04722
Neurotrophin signaling pathway
mcal04750
Inflammatory mediator regulation of TRP channels
mcal04919
Thyroid hormone signaling pathway
mcal04933
AGE-RAGE signaling pathway in diabetic complications
mcal04935
Growth hormone synthesis, secretion and action
mcal05167
Kaposi sarcoma-associated herpesvirus infection
mcal05169
Epstein-Barr virus infection
mcal05170
Human immunodeficiency virus 1 infection
mcal05171
Coronavirus disease - COVID-19
mcal05200
Pathways in cancer
mcal05205
Proteoglycans in cancer
mcal05206
MicroRNAs in cancer
mcal05214
Glioma
mcal05223
Non-small cell lung cancer
mcal05225
Hepatocellular carcinoma
Module
mcal_M00130
Inositol phosphate metabolism, PI=> PIP2 => Ins(1,4,5)P3 => Ins(1,3,4,5)P4
Brite
KEGG Orthology (KO) [BR:
mcal00001
]
09100 Metabolism
09101 Carbohydrate metabolism
00562 Inositol phosphate metabolism
110300336 (Plcg2)
09130 Environmental Information Processing
09132 Signal transduction
04012 ErbB signaling pathway
110300336 (Plcg2)
04014 Ras signaling pathway
110300336 (Plcg2)
04370 VEGF signaling pathway
110300336 (Plcg2)
04064 NF-kappa B signaling pathway
110300336 (Plcg2)
04066 HIF-1 signaling pathway
110300336 (Plcg2)
04020 Calcium signaling pathway
110300336 (Plcg2)
04070 Phosphatidylinositol signaling system
110300336 (Plcg2)
04072 Phospholipase D signaling pathway
110300336 (Plcg2)
09150 Organismal Systems
09151 Immune system
04611 Platelet activation
110300336 (Plcg2)
04613 Neutrophil extracellular trap formation
110300336 (Plcg2)
04625 C-type lectin receptor signaling pathway
110300336 (Plcg2)
04650 Natural killer cell mediated cytotoxicity
110300336 (Plcg2)
04662 B cell receptor signaling pathway
110300336 (Plcg2)
04664 Fc epsilon RI signaling pathway
110300336 (Plcg2)
04666 Fc gamma R-mediated phagocytosis
110300336 (Plcg2)
04670 Leukocyte transendothelial migration
110300336 (Plcg2)
04062 Chemokine signaling pathway
110300336 (Plcg2)
09152 Endocrine system
04935 Growth hormone synthesis, secretion and action
110300336 (Plcg2)
04919 Thyroid hormone signaling pathway
110300336 (Plcg2)
09156 Nervous system
04722 Neurotrophin signaling pathway
110300336 (Plcg2)
09157 Sensory system
04750 Inflammatory mediator regulation of TRP channels
110300336 (Plcg2)
09158 Development and regeneration
04360 Axon guidance
110300336 (Plcg2)
04380 Osteoclast differentiation
110300336 (Plcg2)
09160 Human Diseases
09161 Cancer: overview
05200 Pathways in cancer
110300336 (Plcg2)
05206 MicroRNAs in cancer
110300336 (Plcg2)
05205 Proteoglycans in cancer
110300336 (Plcg2)
09162 Cancer: specific types
05225 Hepatocellular carcinoma
110300336 (Plcg2)
05214 Glioma
110300336 (Plcg2)
05223 Non-small cell lung cancer
110300336 (Plcg2)
09167 Endocrine and metabolic disease
04933 AGE-RAGE signaling pathway in diabetic complications
110300336 (Plcg2)
09172 Infectious disease: viral
05170 Human immunodeficiency virus 1 infection
110300336 (Plcg2)
05171 Coronavirus disease - COVID-19
110300336 (Plcg2)
05167 Kaposi sarcoma-associated herpesvirus infection
110300336 (Plcg2)
05169 Epstein-Barr virus infection
110300336 (Plcg2)
09176 Drug resistance: antineoplastic
01521 EGFR tyrosine kinase inhibitor resistance
110300336 (Plcg2)
09180 Brite Hierarchies
09182 Protein families: genetic information processing
04131 Membrane trafficking [BR:
mcal04131
]
110300336 (Plcg2)
Enzymes [BR:
mcal01000
]
3. Hydrolases
3.1 Acting on ester bonds
3.1.4 Phosphoric-diester hydrolases
3.1.4.11 phosphoinositide phospholipase C
110300336 (Plcg2)
Membrane trafficking [BR:
mcal04131
]
Exocytosis
Calcium ion-dependent exocytosis
Phospholipases
110300336 (Plcg2)
Endocytosis
Macropinocytosis
Phospholipase C
110300336 (Plcg2)
BRITE hierarchy
SSDB
Ortholog
Paralog
GFIT
Motif
Pfam:
PI-PLC-X
SH2
PI-PLC-Y
C2
SH3_1
SH3_9
PH
SH3_2
PH_12
PH_14
GDPD
EF-hand_like
Motif
Other DBs
NCBI-GeneID:
110300336
NCBI-ProteinID:
XP_021026136
Ensembl:
MGP_CAROLIEiJ_G0031610
UniProt:
A0A6P5Q8L0
LinkDB
All DBs
Position
8
AA seq
1265 aa
AA seq
DB search
MTTMVNVDTLPEYEKSQIKRALELGTVMTVFNARKSTPERRTVQMIMETRQVAWSKTADK
IEGFLDIMEIKEIRPGKNSKDFERAKAVRHKAECCFTILYGTQFVLSTLSLATDSKEDAV
KWLSGLKILHQEAMSASTPTMIESWLRKQIYSVDQTRRNSISLRELKTILPLVNFKVSGI
KFLKDKLVEIGAQKDELSFEQFHLFYKKLMFDQQKSILDEFKKDSSVFILGNTDRPDASA
VYLQDFQRFLLHEQQELWAQDLNKVRERMTKFIDDTMRETAEPFLFVDEFLTYLFSRENS
IWDEKYDAVDMQDMNNPLSHYWISSSHNTYLTGDQLRSESSTEAYIRCLRAGCRCIELDC
WDGPDGKPIIYHGWTRTTKIKFDDVVQAIRDHAFVTSSFPVILSIEEHCSVEQQRHMAKV
FKEVLGDMLLTKPTEASADQLPSPSQLREKIIIKHKKLGPKGDVDVNVEDKKDEHKPQGE
LYMWDSIDQKWTRHYCAIADAKLSFGDDIEQAVEEEPVQDTPPTELHFGEKWFHKKVESR
TCAEKLLQEYCAETGAKDGTFLVRESETFPNDYTLSFWRSGRVQHCRIRSTMENGVMKYY
LTDNLTFNSIYALIQHYREAHLRCAEFELRLTDPVPNPNPHESKPWYYDSLSRGEAEDML
MRIPRDGAFLIRKREGTDSYAITFRARGKVKHCRINRDGRHFVLGTSAYFESLVELVSYY
EKHTLYRKMRLRYPVTPELLERYNMERDINSLYDVSRMYVDPSEINPSMPQRTVKALYDY
KAKRSDELTFCRGALIHNVSKEPGGWWKGDYGTRIQQYFPSNYVEDISAGDAEEMEKQII
EDNPLGSLCKGILDLNTYNVVKAPQGKNQKAFVFILEPKKQGDPPVEFATDRVEELFEWF
QSIREITWKMDTKENNMKYWERNQSIAIELSDLVVYCKPTSKTKDHLENPDFREIRSFVE
TKADSIVRQKPVDLLRYNQKGLTRVYPKGQRVDSSNYDPFRLWLCGSQMVALNFQTPDKY
MQMNHALFSLNGRTGYVLQPESMRSEKYDPMPLESQRKILMTLTVKVLGARHLPKLGRSI
ACPFVEVEICGAEYDSNKFKTTVVNDNGLSPVWAPTQEKVTFEIYDPNLAFLRFVVYEED
MFSDPNFLAHATYPIKGIKSGFRSVPLKNGYSEDIELASLLVFCEMRPVLESEEELYSSC
RQLRRRQEELNNQLFLYDTHQNLRGANRDALVKEFNVNENQLQLYQEKCNRRLREKRVSN
SRFYS
NT seq
3798 nt
NT seq
+upstream
nt +downstream
nt
atgaccaccatggtcaacgtggacacccttccagaatatgagaagagtcagatcaagaga
gcgctggagttagggacggtgatgactgtgttcaacgcccgcaaatccaccccagagcgg
aggacagtacagatgatcatggagactcggcaggtggcatggagcaagaccgcggacaag
attgaaggcttcttggacatcatggagataaaggaaatccgtccggggaagaactccaag
gactttgagcgagccaaggctgtccgtcacaaggcagaatgttgcttcaccatcctctac
ggcacccagttcgtcctcagcacgctcagtttggcaacggactcgaaggaggatgcggtg
aagtggctctctggcttgaagatcctacaccaggaagccatgagtgcatccacccccaca
atgattgagagttggctgagaaaacagatttattcagtagatcaaacccgaagaaacagc
atcagcctccgggagctgaagaccatcttgccactggtcaacttcaaagtgagcggcatc
aagtttctcaaggacaagctggtggaaatcggtgcacagaaagatgagctcagctttgaa
cagttccatctcttctataagaaactcatgtttgaccagcaaaaatcgatacttgacgaa
ttcaaaaaggactcctccgtgttcatcctaggaaacacagaccggccggatgcctcggct
gtctacctgcaggacttccagaggtttcttttacatgaacagcaggagctatgggctcag
gatctgaacaaagtccgggagcggatgaccaagtttatcgatgacacaatgagagagact
gcagagcccttcttatttgtggatgagttcctcacgtatctgttctcccgggagaacagc
atctgggacgagaagtatgatgcagtggacatgcaggacatgaacaaccccttgtcccac
tactggatctcctcttcccacaacacgtacctcaccggggaccagctgcgtagtgagtcc
tccacggaagcgtatatccgctgtctgcgtgctggttgccgctgcattgagctggactgc
tgggacgggcctgacgggaagcccattatctaccacggctggacacggaccaccaagatc
aagtttgatgatgttgttcaggccatccgagaccacgcctttgttacctccagcttcccc
gtgatcttgtctatcgaggaacactgcagtgtggagcagcaacgtcacatggccaaggtg
ttcaaggaagtgttaggagacatgctgttgacgaagcccacagaggccagtgctgaccag
ctgccctcacccagtcagcttcgtgagaagatcattatcaagcataagaagctgggtccc
aagggtgacgtcgacgtcaatgtggaggacaagaaagatgagcacaagccccagggcgag
ctgtatatgtgggactccatcgaccagaaatggacgcgccactactgtgccattgctgac
gccaagttgtccttcggtgatgacattgaacaggctgtggaggaggagccggtccaggac
actccccccacggagctgcattttggggagaaatggttccataagaaggtggagagtagg
acctgtgcggagaagctgctgcaagagtactgtgccgagaccggggccaaggacggcacc
ttcctggtgcgggagagcgagaccttccccaacgactacacactctctttctggcggtct
ggccgggtgcagcactgccggatccggtctactatggagaatggggtcatgaagtactac
ctgactgacaacctcacgttcaacagcatctatgcccttatccagcactaccgcgaggca
cacctgcgctgtgcggagttcgagctgcggctcacagacccagtgcccaaccccaaccca
cacgagtccaagccgtggtactatgacagtctgagcaggggggaagcggaggacatgctg
atgcggatcccccgagatggagccttcctcatccggaagcgggaggggaccgactcctat
gccatcaccttcagggccaggggcaaggtgaaacattgtcgcatcaaccgggatggacgc
cacttcgtgctgggcacctctgcctactttgagagcctggtggagcttgtcagctactac
gagaagcatacactctatcgtaagatgcggcttcgataccctgtgaccccggagctcctg
gagcgatataatatggaaagagacatcaactctctctatgacgtcagcaggatgtatgtg
gacccaagtgagatcaacccttccatgcctcagaggaccgtgaaagcactctatgactac
aaagccaagcgcagcgatgagctgaccttctgccgcggtgccctcatccacaatgtctcc
aaggagcccgggggatggtggaaaggggactacgggacccggatccagcagtacttcccg
tccaactatgtcgaggatatctcggcaggagatgctgaggagatggaaaagcagattatt
gaagacaatcccctcgggtctctctgcaaaggcatattggatcttaatacctacaacgtt
gtgaaggccccccaggggaaaaaccagaaagccttcgtctttatcctggagcctaagaaa
cagggagatcctcccgtggagtttgcgaccgaccgtgtggaggagctgtttgagtggttt
cagagcatacgggagatcacttggaagatggacaccaaggagaacaacatgaagtactgg
gagaggaaccagtccatcgccattgagctctcggacttggttgtatactgcaagccaact
agcaaaaccaaggaccatttggaaaatcctgacttccgagaaatccgctcttttgtggag
acgaaggcagacagcattgtcaggcaaaaacctgtcgatctattgcggtacaatcagaag
ggcctgacccgcgtctaccccaagggacagagagttgactcttcgaactatgaccccttc
cgtctgtggctgtgtggctcccagatggtggcactcaatttccagactccagacaagtac
atgcagatgaaccacgcgctgttttcgctcaatgggcggacaggctacgtcctgcagccg
gagagcatgcgctctgagaagtatgacccgatgcccctggagtcccagaggaagatcctg
atgacactcactgtcaaggttcttggtgcacgccacctccctaaactagggcggagtatt
gcctgtccttttgtggaggtggaaatctgcggggctgagtatgacagcaacaaattcaag
acgacggttgtgaatgacaatggcctcagccctgtctgggctccaactcaggagaaggtg
acatttgaaatctatgatccaaaccttgccttcctacgctttgtggtctacgaagaagac
atgttcagtgaccccaacttcctggctcatgccacgtaccccattaaaggcatcaaatcc
ggctttagatcagtccctctgaagaatgggtacagtgaagacatcgaactggcatccctc
ctggttttctgtgagatgaggccagtcctggagagtgaagaggaactctattcctcctgt
cgccaactgcggaggcggcaagaagaactcaacaaccagctcttcctgtacgacacgcac
cagaacctgcgcggagccaaccgtgatgccctggtgaaggagttcaacgttaacgagaat
cagctgcagctctaccaggagaagtgcaaccggaggctgagagagaagagagtaagcaac
agcaggttctactcctag
DBGET
integrated database retrieval system